Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06735027 · ClinicalTrials.gov registry record · NA

Corticosteroid Injection Versus Nerve Block

A NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06735027 is a NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06735027, a NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.

Interventions

  • OTHER intraarticular corticosteroid injection (IACI)
  • OTHER suprascapular nerve block (SSNB)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-02
Est. Completion 2027-01-02
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT06735027

The ClinicalTrials.gov registry entry for NCT06735027 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glenohumeral Arthritis appearing as the primary indexed condition, and to 2 interventions - of which intraarticular corticosteroid injection (IACI) is the first listed.

NCT06735027 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06735027 about?

NCT06735027 is a clinical study titled "Corticosteroid Injection Versus Nerve Block". The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular n...

What is the current status of trial NCT06735027?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-02. Estimated completion is 2027-01-02.

What conditions does trial NCT06735027 study?

This clinical trial studies the following conditions: Glenohumeral Arthritis, Rotator Cuff Arthropathy.

What interventions are being tested in trial NCT06735027?

The interventions under investigation include: intraarticular corticosteroid injection (IACI) (OTHER), suprascapular nerve block (SSNB) (OTHER).

Who is sponsoring clinical trial NCT06735027?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06735027 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glenohumeral Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.